MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z

Early cognitive impairment is associated with specific regional cholinergic denervation in Parkinson’s disease

S. vander Zee, J. Boertien, M. Gerritsen, J. Spikman, T. van Laar (Groningen, Netherlands)
Early detection of Parkinson’s disease motor fluctuations with a wearable inertial sensor

N. Caballol, A. Prats, P. Quispe, M.A Ranchal, S. Alcaine, F. Fondevilla, A. Bayés (Barcelona, Spain)
Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)
Early predictors of Parkinson’s disease and prognosis in relatives

R. Matmurodov, K.h Khalimova, E. Abduqodirov (Tashkent, Uzbekistan)
Early-onset peak dose Levodopa induced dyskinesia in elderly Ethiopian Parkinson’s disease patient

Y. Zewde (Addis Ababa, Ethiopia)
Educating Spanish-Speaking Communities about Parkinson’s, Research Participation and Genetics: A Community Health Worker (Promotores) Model For Outreach

K. Schroeder, S. Osborne, D. Sperlakis, E. Mackenzie, I. Mata, C. Martinez (New York, NY, USA)
Effect of Combined Modality Treatment on Sustained Phonation in Parkinson’s Disease

M. Cannito, N. Roussel, J. Tetnowski, K. Schiller, M. LeDoux, E. Buder, C. Royal-Evans, S. Narayana (Lafayette, LA, USA)
Effect of globus pallidus interna deep brain stimulation on functional connectivity in patients with Parkinson’s disease

CC. Zhang, N.Y He, J. Li, Y.J Lai, L.B Wang, B.M Sun, V. Voon, F.H Yan, D.Y Li (Shanghai, China)
Effect of herbal medicine against Parkinson’s Diseases- An in silico studies

S. Subramani, Y. Gupta, R. Sharma, P. Prasad (Gwalior, India)
Effect of home-based functional training program on enhancing gross and fine upper extremity function in people with Parkinson’s disease – a randomized controlled trial

M.Y Mak, L.J Ren, I.K Wong-Yu (Hong Kong SAR, China)
Effect of Lactobacillus casei supplementation on clinical response, gut microbiota and faecal metabolites in patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled trial

X.D Yang, X.Q He, S.Q Xu, VV. Qian, Y. Zhang, YY. Song, Q. Xiao (Shanghai, China)
Effect of Levodopa-Carbidopa Intestinal Gel Versus Optimized Medical Treatment on Dyskinesia in Advanced Parkinson’s Disease Patients: Final Results of the Randomized 12-Week DYSCOVER Study

E.F Alvarez, C. Spanaki, E. Pekkonen, L. Manzanares, Y. Liu, O. Sánchez-Soliño, L. Barbato (Elche, Spain)
Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson’s disease patients

A. Lees, O. Rascol, J. Ferreira, O. Klepitskaya, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)
Effect of opicapone and entacapone on early morning-OFF pattern in Parkinson’s disease patients with motor fluctuations

A. Videnovic, W. Poewe, A. Lees, J. Ferreira, O. Klepitskaya, R. Loureiro, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Boston, MA, USA)
Effect of opicapone and entacapone on levodopa short duration response

P. LeWitt, J. Ferreira, G. Ebersbach, E. Tolosa, G. Liang, R. Loureiro, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Detroit, MI, USA)
Effect of P2X4 Signal Axis on Iron Metabolism in Parkinson’s Disease Animal Model

A. Xie, J. Gao, J. Ma (Qingdao, China)
Effect of regular practice of yoga versus aerobic exercise on motor and non motor signs and motor cortex plasticity in Parkinson’s disease

A. Kishore, P. James, A. Thejaus, S. Krishnan, K. Divya, S. Meunier (Trivandrum, India)
Effect of repetitive transcranial magnetic stimulation with intensive physical therapy in cerebellar ataxia: A pilot study

J.H. Ahn, J. Song, M. Kim, J.K. Mun, J.S. Kim, J.W. Cho, W.H. Chang, J. Youn (Seoul, Republic of Korea)
Effect of the MAO-B inhibitor and glutamate modulator safinamide on depressive symptoms in three Parkinson’s disease patients

W.E Hofmann (Aschaffenburg, Germany)
Effect on somatosensory pathway and balance control after unilateral MRgFUS Vim thalamotomy in patients with essential tremor

J.H Chen, C.T Hong, D. Wu, C.J Hu (New Taipei City, Taiwan)
Effectiveness and Tolerability of Mirabegron and Behavioral Therapy in Patients with Parkinson’s Disease and Overactive Bladder: A Prospective, Randomized, Placebo-Controlled Pilot Study

S. Ray, D. Burdick, P. Agarwal, A. Madan (Kirkland, WA, USA)
Effectiveness of Carbidopa/Levodopa Enteral Suspension (CLES) in Advanced Parkinson’s Disease (APD) Patients with Moderate to Severe Fatigue: Sub-group Analysis from PROviDE study

S. Isaacson, J. Aldred, D. Cella, P. Kandukuri, N. Gupta, Y. Jalundhwala, P. Kukreja, I. Pan, R. Pahwa (North Chicago, IL, USA)
Effectiveness of case management interventions in reducing common preventable complications associated with Parkinson’s Disease: A Systematic Review and Meta-analysis

A. van Halteren, J. Janssen Daalen, J. Ypinga, B. Bloem, M. Meinders, M. Munneke, S. Darweesh (Nijmegen, Netherlands)
Effectiveness of dopaminergic drugs on motor symptoms in Parkinson’s disease patients with deep brain stimulation of subthalamic nucleus

L.K SAHOO, D. Batra, N. Kamble, R. Yadav, D. S, P. Pal (Bangalore, India)
Effectiveness of lead position with microelectrode recording based support vector machine for characterizing the sub-cortical-structures via deep brain stimulus in Parkinson`s disease

V. Rama Raju (Hyderabad, India)
Effectiveness of onabotulinumtoxinA on reduction of rest tremor in Parkinson’s disease: A pilot study

D. Roque, D. Drazheva, N. Browner, M. Sklerov, M. Collins (Chapel Hill, NC, USA)
Effects of a community-based adapted boxing program on physical capacity and quality of life in individuals with Parkinson disease over a 12 month period

S. Benoit, E. Riesco, A. Tanguay (Sherbrooke, QC, Canada)
Effects of a next-generation neurotrophic compound in a toxin model of Parkinson’s disease

T. Viljakainen, M. Saarma, M. Voutilainen (Helsinki, Finland)
Effects of Co-Morbidities on Sleep Patterns in Parkinson’s Disease: A Study of 84 Ibadan Patients

R. Oguntoye (Ibadan, Nigeria)
Effects of deep brain stimulation on quality of life and cognition in patients with drug-resistant Tourette syndrome

A. Poddubskaia, A. Gamaleya, A.A Tomskiy, V.. Popov, S.. Asriyants, O. Zaitsev (Moscow, Russian Federation)
Effects of deep transcranial magnetic stimulation of the cerebellum on cerebellar ataxias: A randomized, double-blind, cross-over clinical trial

C. França, D. de Andrade, V. Silva, R. Galhardoni, E. Barbosa, M. Teixeira, R. Cury (Sao Paulo, Brazil)
Effects of Different Side-of-onset on Symptoms, Progression, and Prognosis in Parkinson’s Disease

X. Huang, Y. Huang, C. Liu, X. Huang, Y. Zhang, Q. Ye (Fuzhou, China)
Effects of exosomes devised from dopaminergic neurons overexpressing α-synuclein on autophagy and inflammation in microglia

Y. Liang, L. Bu, E. Tao (Guangzhou,Guangdong, China)
Effects of Expiratory Muscle Training and Air Stacking on Peak Cough Flow in Individuals with Parkinson´s Disease

A. Reyes, A. Castillo, J. Castillo (Viña del Mar, Chile)
Effects of Long-Term Treatment with Fluvoxamine on Non-Motor Symptoms and Neurogenesis in an Early Post-Natal Stress Rat Model of Parkinson’s Disease

E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)
Effects of maximum speed treadmill training on walking capability in children with cerebral palsy

N. Thawinchai (Muang Chiang Mai, Thailand)
Effects of multimodal balance training supported by rhythmical auditory stimuli in people with advanced stages of Parkinson’s disease: A randomized clinical trial

T. Capato, J. Nonnekes, N. de Vries, J. IntHout, E. Barbosa, B. Bloem (São Paulo, Brazil)
Effects of Nabilone on non-motor symptoms of Parkinson´s Disease: A randomised placebo-controlled study (The NMS-Nab Study)

M. Peball, F. Krismer, H.G Knaus, A. Djamshidian, M. Werkmann, F. Carbone, P. Ellmerer, B. Heim, K. Marini, D. Valent, G. Goebel, H. Ulmer, H. Stockner, G.K Wenning, R. Stolz, K. Krejcy, W. Poewe, K. Seppi (Innsbruck, Austria)
Effects of onabotulinum toxin A on balance and gait in Parkinson’s disease with foot dystonia: A case series study

P. Huang, YY. Li, P. Huang, Q. Xiao, Y. Wang, S. Chen, S.D Chen, J. Liu, Y.W Wu (Shanghai, China)
Effects of Rasagiline on Parkinson’s Disease Questionnaire (PDQ-39) Emotional Well-being Domain in Patients with Parkinson’s Disease (PD): A Post-Hoc Analysis of Clinical Trials in Japan

N. Hattori, A. Takeda, Y. Hanya, T. Kitagawa, M. Arai, Y. Furusawa, H. Mochizuki, M. Nagai, R. Takahashi (Tokyo, Japan)
Effects of Sleep Disorders on the Quality of Life in Parkinson’s Disease: A Study of 84 Ibadan Patients

R. Oguntoye (Ibadan, Nigeria)
Effects of Vibrotactile Feedback and Lee Silverman Voice Treatment on Vocal Intensity in Individuals with Parkinson’s Disease: A Preliminary Study

R. Konnai, M. Van Harn, A. Silbergleit (West Bloomfield, MI, USA)
Efficacy and safety of CX-8998 in T-CALM, a randomized, double-blind, placebo-controlled, phase 2a trial in participants with essential tremor: subgroup analysis by baseline tremor severity

H. Jinnah, S. Papapetropoulos, M. Lee, S. Versavel, E. Newbold, R. Pahwa, K. Lyons, R. Elble, W. Ondo, T. Zesiewicz, P. Hedera, A. Handforth, J. Elder, M. Versavel (Atlanta, GA, USA)
Efficacy and Safety of High Doses of Safinamide in Advanced Parkinson’s Disease Patients in a Real-World Experience

F. Rodríguez Jorge, A. Beltrán Corbellini, P. Parra Díaz, J.L Chico García, J. Pagonabarraga Mora, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, P. Pérez Torre, J.C Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects

Y. Masakado, A. Dekundy, A. Hanschmann, R. Kaji (Kanagawa, Japan)
Efficacy and safety of istradefylline in Parkinson’s disease patients with postural abnormality: Results from a multicenter, open-label study in Japan

M. Takahashi, T. Shimokawa, J. Koh, T. Takeshima, H. Yamashita, Y. Kajimoto, A. Mori, H. Ito (Osaka, Japan)
Efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) for advanced Parkinson’s disease: a Turkish single-centre experience

Y. Sucullu Karadag (Ankara, Turkey)
Efficacy and Safety of Opicapone in Parkinson’s Disease Patients According to Duration of Motor Fluctuations: Post-Hoc Analysis of BIPARK-I and II

G. Ebersbach, O. Rascol, J. Ferreira, R. Costa, J.F Rocha, D. Magalhães, P. Soares-da-Silva (Beelitz, Germany)
Efficacy and safety/tolerability of opicapone in catechol-O-methyltransferase inhibitor-naïve Parkinson’s disease patients recently diagnosed with motor fluctuations

A. Lees, J. Ferreira, W. Poewe, H. Gama, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)
Efficacy and security starting safinamide treatment with 100 mg/day in Parkinson’s disease

N. Foncea (Galdakao, Spain)
Efficacy and tolerability of opicapone in Parkinson´s disease in usual clinical practice

V. Gomez-Mayordomo, F. Alonso-Frech, E. Lopez-Valdes, R. Garcia-Ramos, M. Catalan-Alonso (Madrid, Spain)
Efficacy of a Vibrational Armband in Maintenance of Forced Arm Swing in Parkinsonism

A. Harbour, J. VanWart, Z. Mercer, K. Pique, R. Golan, J. Clark, C. Maitland (Tallahassee, FL, USA)
Efficacy of Deep Brain Stimulation for Japanese Patients with Refractory Gilles de la Tourette Syndrome

Y. Kimura, K. Iijima, Y. Takayama, Y. Kaneko, M. Omori, T. Kaido, T. Okada, Y. Kajita, K. Uemura, N. Matsuda, M. Fujiwara, Y. Kano, M. Iwasaki (Kodaira, Japan)
Efficacy of opicapone compared to entacapone in catechol-O-methyltransferase inhibitor-naïve Parkinson’s disease patients recently diagnosed with motor fluctuations: A post-hoc conservative analysis

J. Ferreira, A. Lees, G. Ebersbach, A.T Santos, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Efficacy of opicapone in different levodopa-containing treatment regimens in Parkinson’s disease patients with motor fluctuations

A. Antonini, G. Ebersbach, O. Rascol, F. Ikedo, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Padova, Italy)
Efficacy of unilateral thalamotomy by MRgFUS in essential tremor and Parkinson’s disease in a large cohort of patients

M.C Rodríguez Oroz, O. Parras, A. Gorospe, I. Aviles, P. Manrique, L. Gonzalez, J. Guridi (Navarre, Spain)
Electrochemical skin conductance as a marker of autonomic failure in patients with Multiple System Atrophy

S. Perez-Lloret, V. Fabry, F. Ory-Magne, C. Brefel-Courbon, A. Foubert-Samier, W. Meissner, O. Rascol, J. Senard, A. Pavy-Le Traon (Toulouse, France)
Elevated nigral iron is associated with low plasma serotonin in Parkinson’s disease

L. Jellen, A. Snyder, G. Du, M. Lewis, E. Wang, C. Capan, P. Brundin, L. Brundin, J. Connor, X. Huang (Hershey, PA, USA)
Emergence of stealth polymorphs that escape α-synuclein amyloid monitoring, take over and acutely spread in neurons

F. De Giorgi, F. Laferriere, F. Zinghirino, E. Faggiani, A. Lends, M. Bertoni, X. Yu, A. Gérard, E. Morvan, B. Habenstein, N. Dutheil, E. Doundnikoff, J. Daniel, S. Claverol, C. Qin, A. Loquet, E. Bezard, F. Ichas (Bordeaux, France)
Emerging motor dysfunction in those at-risk of Parkinson’s disease: 5-year follow-up of PREDICT-PD participants

C. Simonet, A. Schrag, J. Bestwick, A. Lees, A. Noyce (London, United Kingdom)
Endocrine Predicts of the Formation of Complex Motor Tics in Tourette’s Disease

D. Labunskiy, E. Yurasova, N. Kurgaev, S. Kiryukhina, V. Podsevatkin, D. Baranov (Saransk, Russian Federation)
Endophenotyping adult-onset isolated cervical dystonia: Does period of onset of mood disorder matter?

I. Ndukwe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)
Endorsement of self-reported non-motor symptoms is associated with higher self-rated motor experiences of daily living in MDS-UPDRS part 2 in Parkinson’s disease

A. Thomann, K. Taylor, F. Lipsmeier, D. Trundell, G. Pagano, S. Zolfaghari, R. Postuma (Basel, Switzerland)
Endoscopic Characteristics of Swallowing Dysfunctions in Multiple System Atrophy

A. Vogel, T. Warnecke, I. Claus, S. Ahring, D. Gruber, H.J Heinze, R. Dziewas, G. Ebersbach, F. Gandor (Beelitz-Heilstätten, Germany)
Endovascular therapy in acute ischemic stroke(AIS)

M. Munteanu (Bucharest, Romania)
Engaging the Denver Hispanic Community in Parkinson’s Disease Research

M. Fullard, G. Matthewson, S. Holden, R. Mullen, J. Parra Gonzalez, J. Feuerstein, H. Hemley, B. Siddiqi, L. Seeberger (Aurora, CO, USA)
Enhancement of executive functions but not memory by multidomain cognitive group training in Parkinson patients with mild cognitive impairment: A multicenter randomized controlled trial

E. Kalbe, A.K Folkerts, A. Ophey, C. Eggers, S. Elben, K. Dimenshteyn, P. Sulzer, C. Schulte, N. Schmidt, C. Schlenstedt, D. Berg, K. Witt, L. Wojtecki, I. Liepelt-Scarfone (Cologne, Germany)
Enriched burden of rare coding variants in hereditary parkinsonism genes in Parkinson’s disease

Y. Kim, J. Lee, N. Kim, S. Hong, Y. Cho, J. Yoon (Seoul, Republic of Korea)
Epidemiology of Huntington’s Disease (HD) in the US Medicaid Population

A. Exuzides, S. Reddy, E. Chang, C. Paydar, G. Yohrling (South San Francisco, CA, USA)
Epidemiology of Impulse Control Disorders and Association with Dopamine Agonist Exposure in the United States Military

A. Garrett, S. Bazaco, S. Clausen, A. Oetting, S. Stahlman (San Diego, CA, USA)
Essential tremor and essential tremor plus are essentially similar on electrophysiological tremor analysis

R. Anandapadmanabhan, R. Rajan, A. Saini, A. Srivastava (New Delhi, India)
Establishment of a Visual Analog Scale (VAS) for DBS Programming (VISUAL – STIM Trial)

C. Palleis, M. Gehmeyr, J. Mehrkens, K. Boetzel, T. Koeglsperger (Munich, Germany)
Estimation of latent class mixed models towards discovery of subgroup trajectories of MDS-UPDRS part II, part III, and ambulatory capacity in Parkinson’s disease

C. Venuto, R. Zielinski, G. Smith, M. Javidnia, K. Kieburtz (Rochester, NY, USA)
Estimation of the 2020 Global Population of Parkinson’s Disease (PD)

N. Maserejian, L. Vinikoor-Imler, A. Dilley (Cambridge, MA, USA)
Euphoria-inducing lead contacts: mapping of image and electrophysiology in Parkinson’s disease

Y.C Chen, C.H Yeh, P.H Tu, P.L Chen, H. Wu, M.K Yang, C.C Chen (Taoyuan, Taiwan)
Evaluating patient out-of-pocket (OOP) expenses using real world utilization data of botulinum toxins

L. Turner-Stokes, A. Lysandropoulos, S. Wietek, C. Divers (Harrow, United Kingdom)
Evaluating the use of Parkinson’s Kinetigraphs in Patients with Parkinson’s Disease and Frailty

B. Mohamed, L. Evans, M. Shukir, A. Abdullah, C. Thomas (Cardiff, United Kingdom)
Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey

O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)
Evaluation of Birth Order in Parkinson’s Disease

M. Kuzu kumcu, S. Tezcan Aydemir, Ç. Ulukan, M. Sorgun, M. Akbostancı (Ankara, Turkey)
Evaluation of Cortical Excitability in Huntington’s Disease and Parkinson’s Disease

N. Togashi, M. Hamada, Y. Shirota, T. Toda, K. Nishiyama, K. Hasegwa (Sagamihara, Japan)
Evaluation of Proactive and Integrated Management and Empowerment in Parkinson’s Disease (PRIME Parkinson) in The Netherlands a prospective observational study

J. Ypinga, A. van Halteren, E. Henderson, B. Bloem, A. Smink, E. Tenison, M. Munneke, Y. Ben-Shlomo, S. Darweesh (Nijmegen, Netherlands)
Evaluation of the Body Weight Changes and Food Addiction in Parkinson’s Disease patient with Deep Brain Stimulation

I. Yakisikli, M. Saka, A. Zirh, B. Bolluk Kilic (Ankara, Turkey)
Evaluation of the effect of Bilateral Subthalamic Nucleus Deep Brain Stimulation on fatigue in Parkinson’s disease

C. Lazcano Ocampo, K. Ashkan, D. van Wamelen, M. Samuel, M. Silverdale, A. Rizos, H. Dafsari, A. Sauerbier, J. Koch, A. Podlewska, V. Leta, L. Timmermann, K. Chaudhuri (London, United Kingdom)
Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease

S. Frank, C. Vaughan, D. Stamler, D. Oakes, M. Davis, N. Gross, M. Gordon, J.M Savola, M. Wieman, S. Eberly, E. Kayson, J. Whaley, J. Goldstein, C. Testa (Boston, MA, USA)
Evidence towards the clinical benefits of using directional leads in Deep Brain Stimulation for movement disorders: Consecutive case series

M. Contreras, J. Saavedra, J. Espinoza, G. Arango, T. Lopez (La Serena, Chile)
Evolution of Freezing of Gait in Subthalamic Nucleus Deep Brain Stimulation

F. Alonso-Frech, V. Gomez-Mayordomo, M. del Valle-Loarte, C. Fernandez-Garcia, M. Hidalgo-Gonzalez, E. Lopez-Valdes, R. Garcia-Ramos, M. Catalán-Alonso (Madrid, Spain)
Examining the Effects of a Dental Mouthpiece on Motor Signs in Parkinson’s Disease

D. May, K. Rawson, D. Moeller, L. Tueth, R. Duncan, E. Harrison, A. Horin, P. Myers, G. Earhart (St. Louis, MO, USA)
Excessive Daytime Sleepiness in Parkinson’s disease and Narcolepsy Genetic Risk Allele HLA DQB1*0602

S. Azher, E. Molho, A. Hahn, O. Adam (Albany, NY, USA)
Experiences of people with Parkinson’s disease exercising at a centre and at home

A. Flynn, N. Allen, C. Canning, E. Preston, S. Dennis (Lidcombe, Australia)
Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)
Exploring dopamine transporter single-photon emission computed tomography quantification as a measure of disease progression in idiopathic Parkinson’s disease

J. Gurwell, R. El Khouli, G. Quintero, J. Slevin, M. Yazell, C. van Horne (Lexington, KY, USA)
Exploring the pathophysiology of acquired dystonia by the use of high frequency somatosensory stimulation

A. Latorre, L. Rocchi, J. Rothwell, K. Bhatia (London, United Kingdom)
Exploring the physiological mechanisms of tremor reduction with bimanual performance in Essential tremor patients

P. McGurrin, F. Vial, T. Osterholt, I. Khan, D. Haubenberger, M. Hallett, D. Ehrlich (Bethesda, MD, USA)
Exploring the role of the retrograde procedural memory in PD in the Luxembourg Parkinson’s Disease Study

L. Pauly, C. Pauly, G. Hipp, M. Hansen, V. Schröder, R. Krüger (Belvaux, Luxembourg)

Jump to: View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z